Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells

Multidrug resistance protein-1 (MDR1) has been proven to be associated with the development of chemoresistance to imatinib (Glivec, STI571) which displays high efficacy in treatment of BCR-ABL-positive chronic myelogenous leukemia (CML). However, the possible mechanisms of MDR1 modulation in the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wu, Song, Li, Chen, Xi-Lei, Zeng, Xiang-Feng, Wu, Jian-Zhang, Zhu, Cai-Rong, Huang, Tao, Tan, Xiang-Peng, Lin, Xiao-Mian, Yang, Qi, Wang, Ji-Zhong, Li, Xiao-Kun, Wu, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042009/
https://www.ncbi.nlm.nih.gov/pubmed/27050374
http://dx.doi.org/10.18632/oncotarget.8489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042009/
https://www.ncbi.nlm.nih.gov/pubmed/27050374
http://dx.doi.org/10.18632/oncotarget.8489

Ejemplares similares